A major study has found that convalescent plasma does not reduce the risk of intubation or death for COVID-19 patients. However, the study also revealed that the antibody profile in the blood of people who have had the virus ...
Sep 9, 2021
0
209
A large, retrospective, multicenter study involving Washington University School of Medicine in St. Louis indicates that convalescent plasma from recovered COVID-19 patients can dramatically improve likelihood of survival ...
Jun 17, 2021
0
15
A new study from researchers at Johns Hopkins Bloomberg School of Public Health and colleagues suggests a slowdown in the use of convalescent plasma to treat hospitalized COVID-19 patients led to a higher COVID-19 mortality ...
Jun 7, 2021
0
0
A randomized double-blind controlled trial of convalescent plasma for adults hospitalized with severe COVID-19 found that mortality at 28 days in the treatment arm was half the rate seen in the control arm (12.6% vs. 24.6%), ...
May 17, 2021
0
4
Convalescent plasma, the use of survivors' antibodies transfused into sick COVID-19 patients is safe and significantly improves clinical outcomes when using high levels of antibodies, according to a new publication by scientists ...
Apr 5, 2021
0
10
Pfizer's coronavirus vaccine does successfully neutralize the more contagious P.1 variant of the virus recently discovered in Brazil, new research shows.
Mar 9, 2021
0
7
Using convalescent plasma, Griffith University researchers have identified how it may be possible to make a future vaccine that will provide protection against all major strains of COVID-19.
Mar 8, 2021
0
21
A laboratory-developed pseudovirus containing the mutations found in the SARS-CoV-2 501Y.V2 variant (first detected in South Africa) was resistant to neutralization when exposed to three types of COVID-19 therapeutic antibodies ...
Mar 4, 2021
1
1
A year ago, when U.S. health authorities issued their first warning that COVID-19 would cause severe "disruption to everyday life," doctors had no effective treatments to offer beyond supportive care.
Mar 1, 2021
0
11
The optimal timeframe for donating convalescent plasma for use in COVID-19 immunotherapy, which was given emergency use authorization by the Food and Drug Administration in August 2020, is within 60 days of the onset of symptoms, ...
Feb 25, 2021
0
38
